The dilemma of testosterone supplementation therapy for male testosterone deficiency and its possible causes
10.3760/cma.j.issn.1000-6699.2019.02.001
- VernacularTitle:男性低雄激素血症睾酮补充治疗的困境及其原因分析
- Author:
Wei LIU
1
;
Shengxian LI
Author Information
1. 上海交通大学医学院附属仁济医院内分泌代谢科 200127
- Keywords:
Hypogonadism;
Testosterone;
Replacement therapy;
Late-onset hypogonadism;
Cardiovascular risk
- From:
Chinese Journal of Endocrinology and Metabolism
2019;35(2):93-98
- CountryChina
- Language:Chinese
-
Abstract:
Due to prolonged life expectancy, people's requirements for quality of life are also increasing. As a protein anabolic hormone, testosterone not only improves muscle and bone health, but also improves energy and sexual function. It is widely used in middle-aged and elderly people, especially in patients with delayed-onset hypogonadism( LOH). However, as several clinical studies have found that testosterone supplementation increases cardiovascular risk, the use of testosterone decreased sharply, and some patients who require testosterone therapy thus do not receive treatment timely. This article summarizes the current clinical research results and analyzes the dilemma of testosterone supplementation therapy.
